Seasoned investor and operating executive focused on value-oriented private equity and growth investments across technology, industrials and healthcare. Thomas Dobbins combines prior investment banking and corporate operating experience to lead carve-outs, operational turnarounds and board-level strategy. Active in deal sourcing, portfolio transformation and capital structure optimization, he is known for hands-on governance and exit-driven value creation. Frequent collaborator with PE sponsors, management teams and institutional investors.
Seasoned investor and operating executive focused on value-oriented private equity and growth investments across technology, industrials and healthcare. Thomas Dobbins combines prior investment banking and corporate operating experience to lead carve-outs, operational turnarounds and board-level strategy. Active in deal sourcing, portfolio transformation and capital structure optimization, he is known for hands-on governance and exit-driven value creation. Frequent collaborator with PE sponsors, management teams and institutional investors.
Value-driven private equity investor and operator specializing in technology, industrials and healthcare. Emphasizes carve-outs, operational turnarounds and capital structure optimization to convert underperforming assets into exit-ready businesses. Combines investment-banking rigor with hands-on governance, active board engagement and close collaboration with sponsors and management. Underwriting prioritizes cash-flow improvement, margin expansion and realistic exit pathways over multiple-year horizons, with disciplined leverage and tactical bolt-on growth.
Value-driven private equity investor and operator specializing in technology, industrials and healthcare. Emphasizes carve-outs, operational turnarounds and capital structure optimization to convert underperforming assets into exit-ready businesses. Combines investment-banking rigor with hands-on governance, active board engagement and close collaboration with sponsors and management. Underwriting prioritizes cash-flow improvement, margin expansion and realistic exit pathways over multiple-year horizons, with disciplined leverage and tactical bolt-on growth.
| Trades 3051 | Longs Won 2192/3051 71% | Profit Factor 8.41 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $375,259.9 |
| Average Win $68,262.16 | Best Trade (Dec 31) $14.23M | Sharpe Ratio -10.56 |
| Average Loss -$20,702.47 | Worst Trade (Oct 16) -$821,870.28 | Z-Score 12.99 (100%) |
| Commissions $0 | Avg. Trade Length 1y 3m 3w 1d | Expectancy $43,214.43 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 21,277 | 19,149 | 17,021 | 14,894 | 12,766 | 10,638 | 8,511 | 6,383 | 4,255 | 2,128 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 189,533 | $53.75M | $65.26M | - | $11.51M | 21.41% | +0.678% |
ABBV AbbVie Inc. | 3,936 | $826,102.13 | $1.12M | - | $294,791.95 | 35.68% | +0.487% |
ABT Abbott Laboratories | 6,336 | $770,509.01 | $664,076.16 | - | -$106,432.85 | -13.81% | +0.124% |
ACN Accenture plc Class A | 1,872 | $455,247.59 | $424,036.08 | - | -$31,211.51 | -6.86% | +0.709% |
ACWI iShares MSCI ACWI ETF | 2,951 | $284,256.17 | $467,143.3 | - | $182,887.13 | 64.34% | -0.584% |
ACWX ISHARES MSCI ACWI EX U.S. ETF | 673 | $47,134.17 | $50,027.45 | - | $2,893.28 | 6.14% | -0.409% |
ADI Analog Devices, Inc. | 2,250 | $607,210.7 | $911,250 | - | $304,039.3 | 50.07% | +0.26% |
ADP Automatic Data Processing Inc. | 991 | $266,001.56 | $283,673.75 | - | $17,672.19 | 6.64% | +0.21% |
AGG iShares Core U.S. Aggregate Bond ETF | 2,713 | $270,664.59 | $258,413.25 | - | -$12,251.34 | -4.53% | -0.168% |
ALC Alcon Inc. | 3,559 | $280,497.06 | $235,997.29 | - | -$44,499.77 | -15.86% | -0.406% |
AMAT Applied Materials, Inc. | 1,963 | $718,796.44 | $818,767.3 | - | $99,970.86 | 13.91% | -3.002% |
AMD Advanced Micro Devices, Inc. | 4,626 | $997,520.06 | $2.51M | - | $1.51M | 151.29% | -3.623% |
AMGN Amgen Inc. | 4,966 | $1.75M | $2.16M | - | $406,901.63 | 23.22% | +0.184% |
AMZN Amazon.com Inc | 25,241 | $5.78M | $6.35M | - | $570,855.66 | 9.88% | -1.305% |
ANET Arista Networks, Inc. | 1,861 | $254,896.11 | $332,932.9 | - | $78,036.79 | 30.62% | -3.6% |
AOA iShares Core Aggressive Allocation ETF | 4,321 | $361,510.48 | $419,007.37 | - | $57,496.89 | 15.9% | -0.493% |
AON Aon plc | 691 | $229,246 | $200,383.09 | - | -$28,862.91 | -12.59% | +1.112% |
AOR iShares Core 60/40 Balanced Allocation ETF | 272 | $16,752.82 | $18,592.56 | - | $1,839.74 | 10.98% | -0.43% |
APD Air Products and Chemicals, Inc. | 1,143 | $333,094.96 | $340,476.84 | - | $7,381.88 | 2.22% | +0.432% |
APH Amphenol Corporation | 15,660 | $538,371.83 | $1.26M | - | $718,969.57 | 133.55% | -1.473% |